Bayer
View Brand PublisherCollaborate with Bayer to solve healthcare challenges through a potential project deal
Are you interested in working with Bayer to solve healthcare challenges the world is facing today? Bayer believes in a collaborative approach to driving innovation in healthcare, and is looking to partner with mature health tech startups and healthcare innovators to achieve this.
If you’re a digital health start-up or company with a ready-to-go healthcare innovation, collaboration with Bayer is just the thing your solution needs to go big and global. Bayer can be that strong and reliable global partner who can help you take your work to the next stage and make the most out of its potential.
What is the G4A Global Dealmaker programme?
The G4A Global Dealmaker program 2018 is tailored for mature start-ups and companies that have a ready to go solution! If you qualify, you will be invited to Berlin to pitch your solution, discuss collaboration options and if everyone agrees, sign a letter of intent for a project (Travel costs covered). The programme offers quality facetime between you and Bayer experts for one full day.
Focus areas of the G4A Dealmaker 2018 program
You can apply to address one or multiple challenges. Applications are open till July 8, 2018, and new focus areas could be added to this list, do visit the site to check for updates. You can also register for an account now and receive prompts as soon as new focus areas are added.
Be among Dealmaker’s impressive alumni
Alumni of the program include: MedShr, a peer-to-peer learning platform for physicians, which is working with Bayer to facilitate exchange of physicians on women’s health topics. Kaiku, a platform for patient reported outcomes, which partnered with Bayer to improve patient experience in oncology trials.
Last year alone, the Dealmaker 2017 program brought together 80 digital health innovators and Bayer experts, leading to more than 10 partnerships.
A fantastic partner in Bayer for your healthcare innovation
For over 150 years, Bayer has been researching and developing innovative healthcare that help make a difference to lives around the world. Bayer is the only global company simultaneously researching improvements in human, animal and plant health. Complementing their comprehensive in-house expertise with partners from academia and industry is integral to their innovation strategy.
Strong partnerships have the power to spark innovation that your organization may not be able to create on its own. Working with Bayer through the Dealmaker programme offers you visibility with one of the world’s largest Life Sciences companies, giving you and your solution a global platform and an entry into Bayer’s G4A Digital Health community.
The application process
Submission deadline: July 8, 2018
Each participant has to complete the submission form and upload a pitch deck before July 8, 2018, 11:59 PM GMT.
Evaluation: July 2018 to August 2018
During evaluation, the G4A jury as well as Bayer experts will review the applications and pick the most promising candidates for the Dealmaker Day in October.
Decision: Early September, 2018
After the final round of selection by the jury, the finalists will be informed and invited to the Dealmaker Day in October.
Dealmaker Day: October 9, 2018
The selected innovators will be invited to Bayer in Berlin to finalize discussions about the potential commercial deal and, if everyone agrees, sign a Letter of Intent.